Identification of Promising Targets for Tolerance Induction Following Heart Transplantation.

被引：0
|
作者：
Klaeske, K. [1 ]
Dieterlen, M. -T. [1 ]
Fischer, J. [1 ]
Hahn, J. [1 ]
Jawad, K. [1 ]
Garbade, J. [1 ]
Mohr, F. [1 ]
Lehmann, S. [1 ]
机构：
[1] Heart Ctr Leipzig, Clin Cardiac Surg, Leipzig, Germany
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
C305
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [41] Thrombocytopenia following liver transplantation.
    Chatzipetrou, MA
    Weppler, D
    Tsaroucha, A
    Iaria, G
    Lupo, F
    Kenyon, NS
    Ricordi, C
    Tzakis, AG
    GASTROENTEROLOGY, 1998, 114 (04) : A1224 - A1224
  • [42] Success of geriatric heart transplantation.
    Go, SE
    Almeda, NP
    Hamilton, M
    Kobashigawa, JA
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (01) : S168 - S168
  • [43] Malignancy following lung transplantation.
    Khanshour, Ammar
    Abu Awwad, Raed
    Chapman, Robert
    Betensley, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] INDUCTION OF TRANSPLANTATION TOLERANCE
    MAJOOR, GD
    VRIESMAN, PJCV
    IMMUNOLOGY TODAY, 1986, 7 (04): : 98 - 99
  • [45] Heart transplantation. Current situation
    Schramm, Rene
    Gummert, Jan F.
    CHIRURGIE, 2024, 95 (02): : 101 - 107
  • [46] Combined kidney and bone marrow transplantation for induction of mixed chimerism and renal allograft tolerance in HLA mismatched transplantation.
    Kawai, T
    Sachs, DH
    Spitzer, T
    Sykes, M
    Tolkoff-Rubin, N
    Delmonico, F
    Saidman, S
    Shaffer, J
    Dey, B
    McAfee, S
    Williams, W
    Ko, D
    Hertl, M
    Goes, N
    Wong, WC
    Colvin, RB
    Cosimi, AB
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 491 - 491
  • [47] Renal transplantation for end-stage renal disease following lung or heart/lung transplantation.
    Erturk, S
    Hertz, M
    Matas, A
    Savik, K
    Ishani, A
    Rosenberg, M
    TRANSPLANTATION, 2000, 69 (08) : S234 - S234
  • [48] Induction treatment with Thymoglobuline® in kidney transplantation.
    Lebranchu, Y
    TRANSPLANTATION, 2000, 69 (08) : S158 - S158
  • [49] Role of daclizumab as a calcineurin inhibitor-sparing agent following heart transplantation.
    Namba, JM
    Kenyon, KW
    Fishbein, DP
    PHARMACOTHERAPY, 2005, 25 (10): : 1490 - 1491
  • [50] Sirolimus use in children following heart transplantation. Clinical and metabolic effects.
    Hathout, E
    Shankel, T
    Cutler, D
    Tan, R
    Fitts, J
    Johnston, J
    Bailey, L
    Chinnock, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 177 - 177
12345